Neurocritical Care

, Volume 13, Issue 1, pp 101–108 | Cite as

Intra-Aortic Balloon Pump Counterpulsation in the Setting of Subarachnoid Hemorrhage, Cerebral Vasospasm, and Neurogenic Stress Cardiomyopathy. Case Report and Review of the Literature

  • Christos LazaridisEmail author
  • Gustavo Pradilla
  • Paul A. Nyquist
  • Rafael J. Tamargo
Practical Pearl



The management of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH) can be often complicated by the presence of stunned myocardium and left ventricular failure. Vasopressors and inotropes are commonly used to optimize mean arterial pressure (MAP) and cerebral perfusion pressure (CPP). Intra-aortic balloon counterpulsation pump (IABP) may be indicated in the management of these patients.


We report the case of a 55-year-old patient who suffered an aSAH complicated by severe left ventricular failure, who subsequently developed symptomatic cerebral vasospasm. Left ventricular failure precluded traditional hemodynamic augmentation, and IABP was successfully used instead, which allowed for reinstitution of hypertensive hypervolemic therapy and prevented delayed cerebral ischemia.


A review of the literature conducted on symptomatic cerebral vasospasm after aSAH and severe left ventricular failure revealed seven publications describing 14 patients with aSAH treated with an IABP during the period of vasospasm.


Intra-aortic balloon counterpulsation pump (IABP) is used for hemodynamic support of patients in cardiogenic shock and its use in the setting of aSAH, cardiomyopathy, and cerebral vasospasm can be beneficial in preventing delayed ischemic deficits.


Intra-aortic balloon counterpulsation Subarachnoid hemorrhage Cerebral vasospasm Takotsubo cardiomyopathy 



We thank Yoshinori Kato Ph.D. for his assistance with translation of the article by Sato et al.


The authors have no financial interest in the technique or instrumentation discussed in this article. No financial or material support was provided to any of the authors in relation to the reporting or preparation of this manuscript.


  1. 1.
    Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41:737–42.CrossRefPubMedGoogle Scholar
  2. 2.
    Acar C, Fabiani JN, Jebara V, Stephan Y, Perier P, Dreyfus G, Couetil JP, Deloche A, Carpentier A. Arterial injuries caused by the insertion of an intra-aortic counterpulsion balloon. Ann Cardiol Angeiol. 1990;39(1):17–9. (French).Google Scholar
  3. 3.
    Ako J, Honda Y, Fitzgerald PJ. Tako-tsubo-like left ventricular dysfunction. Circulation. 2003;108:e158. (Letter).CrossRefPubMedGoogle Scholar
  4. 4.
    Apostolides PJ, Greene KA, Zabramski JM, Fitzgerald JW, Spetzler RF. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery. 1996;38(5):1056–9. (discussion 1059–60, 1996).CrossRefPubMedGoogle Scholar
  5. 5.
    Brouwers PJAM, Wijdicks EFM, Hasan D, Vermeulen M, Wever EFD, Frericks H, et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke. 1989;20:1162–7.PubMedGoogle Scholar
  6. 6.
    Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systemic review: transient left ventricular apical ballooning: a syndrome that mimics st-segment elevation myocardial infarction. Ann Intern Med. 2004;141:858–65.PubMedGoogle Scholar
  7. 7.
    Cohen M, Urban P, Chirstenson JT, Joseph DL, Freedman RJ, Miller MF, Benchmark Registry Collaborators, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J. 2003;24:1763–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Connelly KA, MacIsaac AI, Jelinek VM. Stress, myocardial infarction, and the “tako-tsubo” phenomenon. Heart. 2004;90:e52.CrossRefPubMedGoogle Scholar
  9. 9.
    Cushing H. The blood pressure reaction of acute cerebral compression illustrated by cases of intracranial hemorrhage. Am J Med Sci. 1903;125:1017–44.CrossRefGoogle Scholar
  10. 10.
    Donaldson JW, Pritz MB. Myocardial stunning secondary to aneurysmal subarachnoid hemorrhage. Surg Neurol. 2001;55(1):12–6. (discussion 16).CrossRefPubMedGoogle Scholar
  11. 11.
    Doshi R, Neil-Dwyer G. A clinicopathological study of patients following a subarachnoid hemorrhage. J Neurosurg. 1980;52:295–301.CrossRefPubMedGoogle Scholar
  12. 12.
    Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Fujita K, Fukuhara T, Munemasa M, Numba Y, Kuyama H. Ampulla cardiomyopathy associated with aneurysmal subarachnoid hemorrhage: report of 6 patients. Surg Neurol. 2007;68(5):556–61. (discussion 561, 2007).CrossRefPubMedGoogle Scholar
  14. 14.
    Girod JP, Messerli AW, Zidar F, Tang WHW, Brener SJ. Images in cardiovascular medicine. Tako-tsubo-like transient left ventricular dysfunction. Circulation. 2003;107:e120–1.CrossRefPubMedGoogle Scholar
  15. 15.
    Greenhoot JH, Reichenbach DD. Cardiac injury and subarachnoid hemorrhage: a clinical, pathological, and physiological correlation. J Neurosurg. 1969;30:521–31.CrossRefPubMedGoogle Scholar
  16. 16.
    Haley EC, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery: the North American experience. Stroke. 1992;23(2):205–14.PubMedGoogle Scholar
  17. 17.
    Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.CrossRefPubMedGoogle Scholar
  18. 18.
    Hunt WE, Kassell NF, Pertuiset B, Sano K, Teasdale G, de Villiers JC, Drake CG. Report of world federation of neurological surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68:985–6.Google Scholar
  19. 19.
    Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Jiang CY, Zhao LL, Wang JA, Mohammod B. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anticoagulation? J Zhejiang Univ Sci. 2003;4:607–11.CrossRefPubMedGoogle Scholar
  21. 21.
    Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The international study on the timing of aneurysm surgery: part 1-overall management results. J Neurosurg. 1990;73:18–36.CrossRefPubMedGoogle Scholar
  22. 22.
    Kawai S, Kitabatake A, Tomoike H. Takotsubo cardiomyopathy group: Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J. 2007;71(6):990–2.CrossRefPubMedGoogle Scholar
  23. 23.
    Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220.CrossRefPubMedGoogle Scholar
  24. 24.
    Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24(3):636–40.CrossRefPubMedGoogle Scholar
  25. 25.
    Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD Jr, Wijdicks EF. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg. 2006;105(2):264–70.CrossRefPubMedGoogle Scholar
  26. 26.
    Lee VH, Oh JK, Mulvagh SL, Wijdicks EF. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:2315–28.PubMedGoogle Scholar
  28. 28.
    Mayer SA, Fink ME, Homma S, Sherman D, LiMandri G, Lennihan L, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology. 1994;44:815–20.PubMedGoogle Scholar
  29. 29.
    Meisel S, Shochat M, Sheikha SA, Osipov A, Kogan A, Anabussi N, et al. Utilization of low-profile intra-aortic balloon catheters inserted by the sheathless technique in acute cardiac patients: clinical efficacy with a very low complication rate. Clin Cardiol. 2004;27(11):600–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Mindea SA, Yang BP, Bendok BR, Miller JW, Batjer HH. Endovascular treatment strategies for cerebral vasospasm. Neurosurg Focus. 2006;21:E13.PubMedGoogle Scholar
  31. 31.
    Montessuit M, Chevalley C, King J, Faidutti B. The use of intra-aortic counterpulsation balloon for the treatment of cerebral vasospasm and edema. Surgery. 2000;127(2):230–3.CrossRefPubMedGoogle Scholar
  32. 32.
    Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005;112(18):2851–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Neil-Dwyer G, Walter P, Cruickshank JM, Doshi B, O’Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978;2:990–2.CrossRefPubMedGoogle Scholar
  34. 34.
    Nguyen H, Zaroff JG. Neurogenic stunned myocardium. Curr Neurol Neurosci Rep. 2009;9(6):486–91.CrossRefPubMedGoogle Scholar
  35. 35.
    Nussbaum ES, Heros RC, Solien EE, Madison MT, Sebring LA, Latchaw RE. Intra-aortic balloon counterpulsation augments cerebral blood flow in a canine model of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurgery. 1995;36(4):879–84. (discussion 884–6).CrossRefPubMedGoogle Scholar
  36. 36.
    Nussbaum ES, Sebring LA, Ganz WF, Madison MT. Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study. Neurosurgery. 1998;42(1):206–13. (discussion 213–4).CrossRefPubMedGoogle Scholar
  37. 37.
    Parekh N, Venkatesh B, Cross D, Leditschke A, Atherton J, Miles W, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol. 2000;36(4):1328–35.CrossRefPubMedGoogle Scholar
  38. 38.
    Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol. 1988;12(3):600–5.PubMedGoogle Scholar
  39. 39.
    Rosen CL, Sekhar LN, Duong DH. Use of intra-aortic balloon pump counterpulsation for refractory symptomatic vasospasm. Acta Neurochir. 2000;142(1):25–32.CrossRefGoogle Scholar
  40. 40.
    Sato K, Tokairin H, Kato M. Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage. Masui. 2001;50(8):859–62.PubMedGoogle Scholar
  41. 41.
    Simeone FA, Laurent JP, Trepper PJ, Brown DJ, Cotter J. Experimental augmentation of cerebral blood flow by intermittent aortic occlusion. J Neurosurg. 1972;36(6):700–13.CrossRefPubMedGoogle Scholar
  42. 42.
    Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the multicenter cooperative aneurysm study. Crit Care Med. 1995;23(6):1007–17.CrossRefPubMedGoogle Scholar
  43. 43.
    Spann RG, Lang DA, Birch AA, Lamb R, Neil-Dwyer G. Intra-aortic balloon counterpulsation: augmentation of cerebral blood flow after aneurysmal subarachnoid haemorrhage. Acta Neurochir. 2001;143(2):115–23.CrossRefGoogle Scholar
  44. 44.
    Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97(9):1391–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al. Transient left-ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in Japan. J Am Coll Cardiol. 2001;38:11–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35(2):548–51.CrossRefPubMedGoogle Scholar
  47. 47.
    Urban PM, Freedman RJ, Ohman EM, Stone GW, Christenson JT, Cohen M, et al. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. Am J Cardiol. 2004;94(2):181–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–48.CrossRefPubMedGoogle Scholar
  49. 49.
    Zaroff J, Rordorf G, Newell J, Ogilvy C, Levinson J. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999;44:34–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000;13:774–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Christos Lazaridis
    • 1
    Email author
  • Gustavo Pradilla
    • 2
  • Paul A. Nyquist
    • 3
    • 4
  • Rafael J. Tamargo
    • 2
  1. 1.Neurosciences Intensive Care Unit, Departments of Neurology and NeurosurgeryMedical University of South CarolinaCharlestonUSA
  2. 2.Department of Neurological SurgeryJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of Anesthesiology/Critical Care MedicineJohns Hopkins University School of MedicineBaltimoreUSA
  4. 4.Department of NeurologyJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations